Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (5486)	9/5/1998 9:55:00 AM
From: Dauntless	Read Replies (1) \| Respond to of 7041

Linda - only you would agree with Bill I know from experience that discussions with Bill & you are not possible in this format. Your feelings for me really mean nothing as you mean nothing to me and, because I know your background, I understand exactly what you are. Now, if anyone else cares to have a dialog... The price of this stock has always been very volatile - I made several posts a while back where I stated that Zonagen was a very risky investment. Short term fluctuations in price mean NOTHING unless there is a trade. What's important is the condition of the company. Developing biotech/pharma companies are very difficult to evaluate - during the LONG development, clinical trial & FDA review phase most institutional investors, venture capitalists, etc. rate these companies by their performance against milestones & stated goals. Detours and delays forced by technology, and to some degree regulatory, "surprises" are understood and tolerated - as long as they are dealt with properly and are not frequent - there's not enough cash for too many mistakes. Now here's a list of significant milestones reached by Zonagen in just the last year that I recently posted ...... Some said (over & over)... Zonagen will NEVER get a marketing partner - they did Zonagen will NEVER get a patent for Vasomax - they did Zonagen will NEVER get a patent for Chitosan - they did Zonagen will NEVER file their NDA - they did Zonagen will NEVER buy back a single share of their stock - they did Zonagen will NEVER have appreciable sales in Mexico - they did etc., etc...... Take all the cheap shots you care to - this is a company that has accomplished quite a bit, they've pretty much done it on their original timetable (don't bother bringing up the NDA - sh*t happens), they've done it with very low expenditures. They've got LOTS of cash - they'll likely get more soon - they've got lots of projects/milestones lined up. What projects? From Oppenheimer report 1- 2nd half 1998 - European filing for Vasomax 2- Second generation MED combining phentolamine & non-specific phosphodiesterase inhibitor 3- Vasomaxine 4- therapeutic against prostate disease Common sense also says 1- another payment from SGP likely when FDA accepts submission 2- continued growth in revenue in Mexico .................. This is reality - not the uninformed opinions about what the FDA will do or silly crap people choose to focus on in their endless BS posts. I am LONG on this stock - right now I plan on owning it at least until the FDA decides. In the interim I expect that we will get several other indications of successful progress.